Breast
Reconstruction
Surgery

Lesson objective

Describe personally chosen aims and concerns after therapeutic or risk-reducing mastectomy, distinguish them from outside pressure, and keep reconstruction or no reconstruction open without promising physical or emotional benefit.

Topics

• Give the decision a personal starting point: A reconstruction conversation can begin with what the person wants to understand, rather than with a requested operation. Reconstruction after therapeutic or risk-reducing mastectomy concerns rebuilding breast shape; choosing whether to explore it remains a separate question. Try an opening such as, ‘I want to understand what reconstruction could and could not change for me.’ A second sentence might keep no reconstruction open. These are examples of question design, not expected preferences. The NCI describes both reconstruction and declining it. The 2018 BAPRAS/ABS guide places general information alongside specialist consultation. Neither source decides what matters most to an individual or promises that reconstruction will improve their experience of mastectomy.
• Describe priorities without converting them into promises: Appearance in clothing, comfort with scars, sensation, further procedures and everyday responsibilities may matter in different ways. A useful educational sentence names a concern and asks how it relates to the actual proposal: ‘Being able to discuss changes in feeling matters to me; what is uncertain?’ Another person might prefer to focus on avoiding further surgery or learning about a flat chest. The aim is to make a concern understandable, not to rank adults by their priorities. ASPS includes goals and concerns in consultation; BAPRAS discusses variable appearance and sensation experiences. A priority does not become an achievable result because it is strongly felt, carefully written or shared with a supportive person.
• Separate personal wishes from borrowed expectations: An adult supporter can help the person express a question without supplying the answer. In an invented example, ‘My relative thinks reconstruction is necessary’ describes outside pressure; ‘I want to compare the possibilities’ describes the person's present aim. Keeping these sentences separate makes it easier to ask for an explanation addressed to the person who would receive care. The GMC's UK guidance asks doctors to explore what matters to the patient and avoid pressuring them. This course uses that principle to design a voluntary reflection exercise. It assumes neither that relatives are unhelpful nor that any particular appearance carries a preferred identity, confidence level or emotional response.
• Turn a broad hope into an answerable question: A phrase such as ‘I want to feel like myself’ may contain several different concerns. An original question-building method is to add one concrete dimension, one uncertainty and one request for explanation: ‘I am concerned about how my chest may look in clothing; which changes are realistic and which remain unpredictable?’ The person need not replace their own words with technical vocabulary. A clinician can help clarify an unclear hope, including whether reconstruction is wanted at all. General descriptions of rebuilt shape do not establish restored function or emotional benefit. Keep the educational result as a question to discuss, rather than a prediction, a selected approach or a commitment to surgery.

Lesson objective

Identify available breast surgery, cancer treatment, previous implants, health and medicine information for the relevant team; leave gaps explicit without assessing eligibility or treatment. Use invented details in course examples and keep actual health records private.

Topics

• Identify the consultation context without deciding treatment: Therapeutic mastectomy and risk-reducing mastectomy describe different reasons for breast surgery. A reconstruction question may concern a planned mastectomy, a previous operation or a later review, but these labels do not supply the diagnosis, cancer plan or risk assessment. In an educational note, write only the invented context and mark everything else as unknown. NHS information describes both treatment and risk-reduction settings; the 2018 joint guide separately discusses risk-reducing surgery. None authorizes an adult to infer eligibility from a family story or gene label. The relevant teams must establish the actual context, including which breast or breasts and which previous treatments matter to their explanation.
• Keep breast and treatment history intelligible: A useful history question separates what is known from what needs confirmation. Relevant categories may include earlier breast operations, mastectomy details, radiotherapy or other cancer treatment, previous reconstruction and any implants. ASPS includes previous surgeries and medical treatments in consultation; NCI explains that prior treatment and surgery can influence reconstructive discussions. Course notes cannot turn a remembered procedure name into a complete operative record. In a real consultation, ask the responsible service which actual records it needs and how those should be shared through its secure process. In this course, practice with invented placeholders such as ‘previous operation: details not supplied’; do not upload or reproduce an actual health record.
• Ask who reviews health and medicine information: Reconstruction consultation may involve medical conditions, allergies, current medicines, supplements and substance-use history as well as previous surgery. The purpose of noticing these categories is to ask who needs the information and who will explain its relevance. Listing a medicine in an exercise does not indicate that it is safe, unsafe or should be stopped. Similarly, a named condition cannot be used here to approve or exclude an approach. ASPS presents these categories for consultation, while NHS describes discussion with the surgeon or specialist nurse before mastectomy. Keep questions directed to the responsible qualified team: ‘Who reviews this information, and what additional details do you need?’ No course list replaces that review.
• Make gaps visible and protect real records: An incomplete history can still produce a clear question. ‘The date is not supplied’ is more accurate than guessing; ‘the device details need confirmation’ is more useful than treating a remembered brand as verified. Use a simple educational distinction between an invented fact, an invented uncertainty and a question for the team. This format is original course design. Sources support bringing previous operations and treatment context into discussion, not the accuracy of a learner's notes. Actual health and implant records belong in the responsible service's secure clinical process. Keep them out of course exercises, public examples and shared study drafts. Completing an educational summary does not make it a medical record or establish that missing information has been resolved.

Lesson objective

Prepare questions about reconstruction, no reconstruction, flat closure as a surgical closure option and removable external breast forms; distinguish these different discussions from personally suitable or available choices or permission to wait.

Topics

• Keep no reconstruction a distinct discussion: No reconstruction means not rebuilding a breast mound after mastectomy. It is a discussion in its own right, rather than a missing step in an assumed reconstruction pathway. An adult may want to ask what the chest would look and feel like, what closure is proposed and what continuing breast or oncology care remains relevant. The educational task is to identify those questions, not to decide whether the option is personally appropriate. NCI explicitly describes choosing not to reconstruct, and BAPRAS includes no reconstruction among broad choices. An individual's preference supplies no permission to postpone cancer treatment, no guaranteed later option and no promise about body image, clothing comfort or feelings.
• Name flat closure accurately: Flat closure is a surgical chest-wall closure discussion. It should not be confused with simply declining breast reconstruction or with using an external form. NCI explains that forgoing breast-rebuilding procedures does not itself ensure an aesthetic flat closure. A useful question therefore names the desired subject: ‘If I do not want a reconstructed breast mound, can we discuss what closure would involve and what appearance remains uncertain?’ That question neither requests a technique taught by the course nor establishes that flat closure is available or suitable. Keep the distinction visible when reading broad ‘going flat’ language, because the person's intended chest contour and the actual surgical proposal still need qualified discussion.
• Distinguish a removable external breast form: An external breast prosthesis, also called a breast form, is worn outside the body rather than implanted as a reconstruction device. NCI describes it as an option for people who do not reconstruct or who consider reconstruction later. A form is optional: choosing no reconstruction does not require someone to wear one. Question preparation can address where locally relevant advice is available, what fitting or practical information is offered and what costs need confirmation. This course does not select a product, fitting method or wearing schedule. Keeping ‘external removable form’ separate from ‘implanted device’ prevents a practical clothing discussion from being mistaken for a surgical proposal or an agreed supply arrangement.
• Ask about revisiting a choice without assuming future access: A question about later reconstruction is different from a promise that it can always be arranged. Timing, health, previous treatment, available expertise and the actual service may affect the discussion. Compare four headings in an educational note: reconstruction, no reconstruction, surgical flat closure and external removable forms. Under each heading, ask what needs clarification; do not mark a ‘best’ option using general source descriptions. GMC guidance supports discussing reasonable alternatives and uncertainty, while BAPRAS says reconstruction can be reconsidered after initially declining it. That possibility does not establish future eligibility, a reserved appointment, funding or a safe waiting period. Any time-sensitive treatment implications belong to the actual breast and oncology teams.

Lesson objective

Distinguish broad implant-based, own-tissue and combined approaches and ask what the actual proposal includes; no product, donor site, flap, expander sequence or operative method is selected or taught.

Topics

• Recognize an implant-based description: Implant-based reconstruction uses an implanted device to help rebuild breast shape after mastectomy. A broad source may also mention a tissue expander and a later implant, but that description does not mean every proposal contains those stages. Ask which devices and possible stages are actually proposed, and who will explain their purpose and continuing commitments. The goal at this point is vocabulary for a conversation, not a device choice. NCI distinguishes implants from tissue taken from elsewhere in the body; the joint BAPRAS/ABS guide describes the same broad families. The course selects no filling, surface, size, product, placement, expander sequence or operation, and gives no device-specific suitability judgment.
• Recognize an own-tissue description: Own-tissue, or autologous, reconstruction uses tissue from another part of the person's body to help rebuild breast shape. That other area is called the donor site. The term ‘flap’ may appear in a proposal; recognizing the word is enough to ask what tissue source is proposed and what effects need explanation. Different names do not let a learner choose a donor site or judge suitability. NCI describes the broad tissue approach and identifies donor-site considerations; NHS includes tissue from another body area among reconstruction descriptions. Keep the breast result and donor-site questions separate: a discussion about rebuilt shape does not answer what scars, sensation changes, weakness or other limitations may affect the donor area.
• Leave combined proposals open to explanation: Some reconstructions combine an implant with the person's own tissue. ‘Combined’ identifies components, not an assurance that the approach provides the benefits of both without their commitments. If that word appears, ask which components are part of the actual proposal, why each is being discussed and what separate risks or future reviews need explanation. NCI explicitly describes the use of both approaches together. The source does not establish that a combination is suitable for a particular adult or that one approach should be added to another. A clear educational note can simply say ‘combined approach mentioned; details and reasons require the team's explanation’ instead of guessing a device, tissue source or operation.
• Translate terminology into proposal questions: A proposal can contain unfamiliar terms without becoming an assignment to learn surgical technique. Use three original question headings: what is included, what is not yet decided and who explains each commitment. Under ‘included’, distinguish a device from a donor-tissue component. Under ‘not yet decided’, preserve missing information rather than creating a sequence from a general web page. Under ‘who explains’, ask which breast and reconstructive professionals coordinate the account. NCI and the 2018 guide support broad approach distinctions; neither validates a learner's interpretation of a real proposal. The resulting note should remain understandable to an adult without technical training and should leave method selection, examination and consent to actual qualified care.

Lesson objective

Ask how an immediate or later reconstruction proposal relates to actual mastectomy and oncology plans, prior treatment and personal preferences; question preparation supplies no cancer recommendation, timetable, permission to delay cancer treatment or clinical clearance.

Topics

• Use timing terms as descriptions: Immediate reconstruction means reconstruction performed or started at the time of mastectomy; delayed reconstruction refers to reconstruction at a later time. These terms describe timing categories, not a personal recommendation. A source may describe typical relationships to healing or cancer treatment, but it cannot establish the date or readiness of an individual. Ask what the team's timing word means in the actual proposal and whether it describes a possible stage or a confirmed plan. NCI and BAPRAS both introduce immediate and delayed categories. Do not convert their examples into a waiting period, recovery calendar, eligibility rule or permission to defer treatment. An educational question list can retain ‘timing not yet explained’ when details are absent.
• Ask how the actual cancer plan and reconstruction meet: A timing conversation may need both the breast or oncology plan and the reconstructive proposal. For example, prior or anticipated radiotherapy can raise questions about healing, approach and timing. The appropriate question is how the actual teams coordinate those issues for the person, not whether one internet paragraph permits a preferred date. NCI discusses radiotherapy in relation to reconstruction; BAPRAS describes coordination when other treatment affects immediate or later options. These are reasons to request an individual explanation. They supply no cancer-treatment recommendation, no instruction to wait until a treatment ends and no assurance that reconstruction cannot affect practical treatment arrangements. Keep oncology responsibilities visible rather than treating timing as solely a cosmetic preference.
• Identify whose answer is needed: Different timing questions may require different contributors. The breast team can explain the actual mastectomy or treatment context; reconstructive clinicians can explain the proposed reconstruction; other specialists may contribute to coordination. Ask who combines those explanations and how unresolved information will be addressed. BAPRAS's UK service discussion describes breast and plastic surgeons working together, sometimes across hospitals. That historical account does not prove the structure of a particular service or guarantee a referral. NCI's mastectomy information also points to reconstruction experience. A useful educational output names roles to ask about rather than inventing a team, assuming that a general title proves experience or claiming that a clinical date has been accepted.
• Clarify deadlines without creating permission to wait: Reflection time and clinical time limits can both require explanation. Ask whether a particular decision has a deadline, what uncertainty remains and who explains the implications of delaying that decision. This is different from assuming a delay is harmless because reconstruction is optional. GMC guidance for UK doctors includes discussing relevant decision time limits and their implications. In this course, the question is directed to the actual team; it does not authorize postponing mastectomy, cancer treatment or investigation. General descriptions of immediate and delayed reconstruction also do not resolve the deadline. An original note might separate ‘time needed to understand the proposal’ from ‘clinical timing implications awaiting explanation’, leaving both open for qualified discussion.

Lesson objective

Prepare locally relevant questions about the actual breast and reconstructive clinicians, experience, setting and continuing responsibility; titles, images or course completion establish no verified provider or accepted care.

Topics

• Distinguish roles from actual responsibility: ‘The team’ can be too broad to answer a practical question. Ask who explains the breast treatment context, who leads the reconstructive proposal, who provides nursing support and who has overall responsibility when services share care. BAPRAS describes collaboration among breast and plastic specialists in a UK service setting. GMC professional guidance separately addresses identifying responsibility and a lead clinician or team. These sources support asking for roles and ownership; they do not prove that a particular arrangement exists. An educational role map can leave the person's name blank and mark ‘to confirm’. Titles, photographs, promotional biographies and a course question list do not identify the responsible clinician or establish an accepted clinical relationship.
• Check credentials in their actual jurisdiction: Credentials require a locally relevant check and a separate conversation about reconstruction experience. ASPS's questions refer to US training, board certification and hospital privileges; those labels cannot be treated as universal requirements. In the UK, GMC's register guide describes registration, licence and specialist information, while noting that not all specialist consultants must appear on the Specialist Register. Ask which official record applies locally and what the clinician's relevant experience covers. A record alone does not prove competence for every proposal or guarantee a result. The preserved research includes an initially readable GMC guide, native access refusals and a later web timeout; an educational discussion therefore claims no completed check on any real clinician.
• Ask about the proposed setting: Knowing where an operation or later stage may take place is different from verifying that the setting fits the actual proposal. Ask which facility is proposed, what locally relevant oversight applies and how the clinician's privileges or working arrangements relate to it. ASPS includes facility and hospital-privilege questions in its US checklist. BAPRAS describes care that may involve more than one hospital. An educational question should therefore avoid assuming that one address covers every stage or continuing review. A reassuring room photograph, a hospital name or a professional title supplies no proof of facility suitability. The actual service must explain the setting, relevant arrangements and responsibility; this course supplies no accreditation judgment or clearance.
• Clarify delegation and information transfer: A named lead does not answer who carries out every task or how information moves when clinicians change. Ask which duties are delegated, what qualified support is available and how the next clinician receives relevant information. GMC's continuity and delegation sections address those professional responsibilities in the UK. For an adult preparing questions, the practical issue is understanding who accepts each part of care and how an unanswered concern reaches an appropriate professional. An original role map can include ‘who explains’, ‘who carries out’ and ‘who takes over’, all marked unconfirmed until actual discussion. A learner's map is neither an agreed handover nor a clinical record, and it cannot guarantee continuing responsibility across distance or service changes.

Lesson objective

Ask about personally relevant appearance, lasting scars, sensation and donor-site effects, and raise history-dependent feeding questions; rebuilding shape does not promise restored breast function, symmetry or a particular result.

Topics

• Separate shape aims from a guaranteed match: Reconstruction concerns rebuilding breast shape, but a general description cannot promise symmetry, a particular feel or satisfaction. If matching another breast is discussed, ask what changes are proposed and what limitations or further procedures need explanation. ASPS states that outcomes are not guaranteed and additional procedures may sometimes be needed; NCI describes possible other-breast surgery within reconstruction discussions. Neither makes that surgery mandatory or establishes a personally achievable result. A useful educational question names the concern rather than a required endpoint: ‘Which differences could remain, and what would each optional further proposal involve?’ An adult can want information about shape without agreeing to every possible adjustment or expecting restoration of the original breast.
• Ask about breast and donor-site scars separately: Reconstruction leaves scars, and an own-tissue proposal adds questions about the area where tissue is obtained. Ask which sites need discussion, what remains unpredictable in healing and how the surgeon explains lasting marks. BAPRAS notes uncertainty in individual scar outcomes; ASPS explains that scar lines do not disappear completely. An educational question list cannot draw the future scar pattern or decide that a scar will be acceptable to someone. Keep a breast-site concern and a donor-site concern in separate sentences so one does not conceal the other. General descriptions do not establish a scar-treatment plan, a healing timetable, an inevitable visual course or a promise that a particular approach minimizes every lasting effect.
• Keep sensation and donor function distinct: A rebuilt breast shape does not establish normal sensation. Mastectomy can cause numbness and loss of feeling, and the course cannot predict any sensory return. Own-tissue reconstruction also raises donor-area concerns such as pain or weakness; those concerns are different from breast sensation. NCI identifies both sensory changes after mastectomy and donor-site effects. BAPRAS discusses adjustment to changed appearance and feeling. Ask the actual team which lasting changes are relevant, what is uncertain and who can address functional concerns. Do not infer an exercise plan, activity permission or guaranteed rehabilitation outcome. An adult's daily priorities may help frame the conversation, while qualified clinicians remain responsible for interpreting the actual history and proposal.
• Raise feeding questions from the actual history: Rebuilding shape does not replace milk-producing breast tissue removed by mastectomy. FDA's reconstruction-specific discussion links affected-side feeding limits to tissue and gland loss. CDC describes how mastectomy and cancer treatment history can affect milk production and identifies qualified support. Its general statements about another breast must not become a promise of adequate milk production for an individual. Ask which actual surgery and treatment details a qualified team needs, and who can address future feeding questions. Donor-site changes belong in their own discussion; this course does not claim they cause affected-breast feeding loss. It supplies no pregnancy, oncology, infant-feeding, supplementation or monitoring plan and no reassurance about capacity on either side.

Lesson objective

Organize questions about general surgical risks, implant-related problems and uncertain reported conditions, tissue loss and donor-site effects; source lists supply no personal cause, probability, method choice or permission to proceed.

Topics

• Discuss general surgery and donor-site risks: Essential risk questions belong before any reconstruction decision, whatever educational package is used. ASPS lists bleeding, infection, poor wound healing and anesthesia risks, while own-tissue reconstruction can involve partial or complete tissue loss and altered sensation. BAPRAS adds donor-area concerns, fluid collections and blood-clot risks to its broad discussion. These categories help prepare questions about the actual proposal; they are not a complete personal risk assessment. Ask which risks apply, which could have lasting effects and how the team explains uncertainty in light of the person's history. The course gives no probability, prevention method, symptom interpretation or management rule, and does not rank one approach as safest on the basis of a general list.
• Include local device problems and future commitments: An implant proposal needs questions about device-related risks as well as surgery in general. FDA's list includes pain, infection, capsular contracture, rupture and position or sensation changes. Capsular contracture means tightening of scar tissue around an implant; recognizing the term does not diagnose it. Implants are not lifetime devices, and further surgery can be needed, but no universal exchange date follows. Ask what the relevant product information says, what remains uncertain and who explains later commitments. A fictional exercise may group local risks and future procedures under separate headings. Neither grouping selects a device, predicts complications for an adult or guarantees that later removal, replacement or correction will resolve their concerns.
• Keep reported capsule malignancies distinct: BIA-ALCL is an implant-associated lymphoma; it should not be conflated with an adult's breast-cancer history or ordinary breast follow-up. FDA also describes reports of squamous cell carcinoma and other lymphomas in scar tissue around implants. ASPS includes capsule malignancies in reconstruction risk information. A useful question asks the clinician to distinguish these conditions, explain the evidence and discuss what is relevant to the actual device proposal. Reports and general associations do not determine individual cause or probability. This lesson neither selects an implant surface nor supplies a screening, symptom or management pathway. Essential discussion remains necessary even when a condition is uncommon, and naming it in course work is not a diagnosis or a complete disclosure.
• Explain systemic uncertainty and request personal disclosure: Some people with implants report systemic symptoms, and the term ‘breast implant illness’ may appear in discussion. FDA states that these symptoms and their causes are poorly understood. A general report cannot prove that an implant caused one person's symptoms or that removal would relieve them. Ask how the actual team explains the evidence, its limitations and any relevant uncertainty, alongside the other surgical, donor-site and device risks. GMC's UK guidance addresses clear individual discussion of benefits, harms and knowledge limits. This course uses that as a question-preparation principle, not a personal assessment. It supplies no symptom diagnosis, investigation choice, blanket removal recommendation or promised relief, and a completed risk worksheet cannot establish informed consent.

Lesson objective

Ask for understandable alternatives and individual risk information, reflection time and actual itemized financial commitments; a course, checkbox or discussion supplies no consent, funding entitlement or requirement to choose reconstruction.

Topics

• Request an understandable explanation of alternatives: A useful conversation explains the proposal in language the person can understand, including reasonable alternatives and uncertainty. Reconstruction is not established as necessary by an attractive description or a completed question list. Ask what each discussed option aims to change, what it cannot restore and what risks the actual team considers personally relevant. GMC guidance for UK doctors addresses understandable information, objective alternatives and freedom from pressure; ASPS includes questions about options, risks and concerns. These sources support dialogue with qualified care. The course does not supply the individual's explanation or demonstrate that one has occurred. An educational note can identify unanswered questions, but it is not a consent form, a checklist signature or a treatment agreement.
• Preserve reflection without assuming delay is safe: Voluntary reflection can include asking for clarification, bringing a chosen adult supporter or requesting another professional explanation. It does not require a person to share private priorities with the course or to justify declining reconstruction. Ask what time is available to understand the proposal, whether any decision has clinical time limits and how a second opinion can be sought locally. GMC discusses pressure, relevant deadlines and second opinions. The educational exercise leaves actual availability and timing unconfirmed. A request for reflection neither grants permission to delay cancer care nor creates a guaranteed appointment. Distinguish ‘I have questions’ from ‘I have agreed’, so a conversational exchange or an inquiry is not mistaken for consent or accepted care.
• Clarify itemized and continuing financial commitments: Ask for the actual financial explanation before treating an offer as affordable or complete. Original question headings can include the proposed procedure, facility and professional charges, possible later stages, reviews, complications and revision or removal costs. The exact list must be confirmed locally. GMC includes relevant bills in decision information; FDA warns that implant removal or replacement costs may not be covered even when complications occur. Neither source determines an adult's benefits or eligibility. A quoted price, course payment or historic description of US or UK coverage establishes no personal entitlement. Request clarification from the responsible service and payer about what is included, what is conditional and who explains unresolved future commitments.
• Keep device information separate from consent and payment: For an implant proposal, ask for the actual manufacturer's patient information and device details, including the relevant risk communication and later commitments. FDA's page describes US labeling actions taken in 2021, including a patient decision checklist and device card; its displayed current-as-of date is 8 March 2023. These documents do not become a worldwide consent process merely because a learner reads about them. A card identifies device information rather than proving integrity, agreed monitoring or payment coverage. An educational exercise cannot sign a clinical checklist, supply a product's full labeling or establish that a service has accepted responsibility. Keep information received, questions remaining and actual financial terms as separate matters requiring qualified explanation.

Lesson objective

Ask who accepts responsibility for individual preparation, transport and home support, written instructions, necessary supplies, review and qualified in-hours, out-of-hours and unavailable-contact arrangements; essential care remains necessary regardless of package.

Topics

• Identify who provides individual preparation instructions: Essential preparation questions belong before any decision and are not reserved for Full lessons. Ask which breast, reconstructive and anesthesia professionals review personal health, medicines and any investigations, who provides the individual instructions and how unclear or conflicting advice is resolved. ASPS and NHS describe clinician-led preparation; their examples do not become requirements for every adult. The course therefore gives no medicine change, fasting rule, test order, smoking schedule or clearance. An original question note may simply record ‘responsible clinician and written instructions to confirm’. A general web list, an educational package or a fictional completed worksheet cannot replace the actual team's explanation of what is relevant to the person and proposed care.
• Confirm practical support rather than assuming it: Ask what transport, home help and everyday support the actual team considers necessary, who can realistically provide it and what remains unconfirmed. ASPS includes questions about recovery help; BAPRAS discusses home assistance in its broad aftercare account. These descriptions do not prove that a supporter has agreed, that a service supplies transport or that any adult can manage a particular task. An original educational distinction is between an idea for help, a question to ask and a confirmed arrangement. All three remain fictional in course work. Practical preparation must be explained by qualified care in the actual context, without a course-generated recovery timetable, activity permission, caregiver commitment or guarantee of access.
• Ask about written instructions and necessary supplies: An essential-care conversation should identify who supplies written, individual instructions for the actual breast, device or donor sites and who answers questions about them. Ask which necessary supplies, if any, are required, who provides or obtains them and how uncertainties are resolved before they are treated as arranged. ASPS describes individualized instructions and questions about dressings, drains, washing, medicines and activity. The course converts those categories into ownership questions, never into a protocol or shopping list. A household item shown in an illustration or mentioned in an exercise is not verified clinical equipment. Reading a source or buying a course cannot establish that instructions or supplies have been issued, understood or accepted as adequate.
• Confirm review and qualified contact ownership: Before treating care as arranged, ask who owns the relevant reviews and who provides qualified advice during ordinary hours, outside them and when the usual contact is unavailable. Ask how to obtain the locally applicable written escalation routes and who explains unresolved contact instructions. ASPS includes individual concerns and follow-up questions; NHS contains jurisdiction-specific action information; GMC addresses responsibility and transfer of care. These sources support requesting the actual arrangements, not assuming that a phone number ensures a response. This lesson supplies no symptom checklist, urgency rule or emergency number for universal use. A course, inquiry or contact list establishes neither an accepted clinical relationship nor guaranteed availability, and essential contact responsibilities remain necessary regardless of package.

Lesson objective

Ask which proposed devices, possible stages and product information apply, what remains uncertain and who explains future commitments; broad implant descriptions choose no device, surface, size, stage sequence or operation.

Topics

• Name the proposed device and any possible stages: An implant-based proposal needs its own explanation. Ask whether the discussion concerns an expander, a breast implant, a combination with own tissue, or a possibility that remains undecided. If more than one stage is proposed, ask what each stage is intended to address, who would reassess the proposal and what questions remain before later decisions. The NCI description of expanders and later implants supplies useful vocabulary for these questions; it does not make that sequence necessary for every adult. Keep an unanswered device or stage question visible rather than completing it from a generic description. The qualified team explains the actual proposal and its relationship to the mastectomy context.
• Request the actual product information: A broad term such as implant does not identify the proposed product. Prepare questions about its manufacturer, model, materials and relevant labeling, and ask who will explain unfamiliar terms in an understandable way. Ask what device information would be recorded and whether a device card or equivalent record would be provided through actual care. The FDA describes US labeling and decision materials, including a patient decision checklist. That US communication process is useful context, but the course does not supply the proposed labeling, complete a checklist or establish consent in any jurisdiction. Product features, including size and surface, remain matters for qualified discussion rather than selections made from this lesson.
• Keep support materials and risks explicit: If the proposal includes mesh or another support material, ask for its name, intended role and the explanation of benefits, risks and uncertainty in that particular use. Do not assume that an implant label answers a separate material question. Ask how implant-related problems such as contracture or rupture, reported capsule malignancies and reported systemic symptoms will be discussed alongside general surgical risks. These are distinct questions, rather than a diagnosis or a prediction that one adult will develop them. ASPS and FDA descriptions identify areas that require explanation. Their wording does not establish a material’s suitability, a local approval decision, symptom causation or promised relief from a later operation.
• Clarify future commitments before deciding: The proposal discussion also needs questions about future review, possible further surgery and actual financial responsibilities. Ask who would explain changes to the reconstruction, how later concerns would reach qualified care and what costs are included or remain uncertain. Keep an estimate, a warranty statement, an insurance inquiry and an accepted clinical arrangement distinct. FDA information and the older BAPRAS/ABS guide explain why future device questions matter; neither gives a universal implant lifespan or replacement deadline. An educational brief cannot establish that a particular service will provide revision or pay for it. Essential risks and care questions belong to every adult’s actual discussion and were introduced before the Foundation boundary.

Lesson objective

Prepare questions about the actual proposed tissue source, scars, possible donor-site limitations and further care; broad flap terminology supplies no method selection, operative instruction or guaranteed tissue survival or function.

Topics

• Ask which tissue source is actually proposed: Own-tissue reconstruction uses tissue from another part of the person’s body; the source area is therefore part of the discussion as well as the reconstructed breast. Ask the clinician to explain the proposed tissue source and any unfamiliar flap name in relation to the actual history and priorities. Also ask whether a device forms part of the proposal, because broad own-tissue and implant categories can be combined. Vocabulary is useful for understanding an explanation, but a list of flap names is not a selection tool. The lesson does not compare operations to choose a donor site, interpret previous surgery as eligibility, or teach how tissue or blood vessels are moved.
• Include both breast and donor-site scars: A proposal involving own tissue needs questions about more than the breast’s appearance. Ask where the actual team expects scars at the breast and donor area, what uncertainty remains about their appearance and how those possibilities relate to the person’s chosen priorities. A general illustration or another person’s photograph cannot establish a particular scar pattern or healing result. The BAPRAS material supports discussing scars at both sites and the limits of prediction. Its descriptions should open questions rather than set a schedule for scar change. Keep preference statements, such as wanting to discuss an additional scar, separate from a claim that one method will produce a preferred result.
• Discuss donor-site function and tissue risks: Ask what the proposed tissue source could mean for sensation, discomfort, weakness or other donor-site effects that matter to the adult’s everyday life. Keep these questions beside risks involving the reconstructed area, including healing problems and partial or complete tissue loss. NCI, BAPRAS and ASPS descriptions show why breast and donor areas need separate explanation. They do not establish that one adult will experience a listed problem or avoid it. Ask the qualified team which risks and uncertainties apply to the actual proposal and how concerns would be managed within accepted care. The course supplies no self-check method, probability, prevention instruction or guarantee of tissue survival or function.
• Ask how further care covers both areas: Clarify how the proposed care discussion covers the breast and donor area, including who explains possible problems and who would hold responsibility if further treatment is considered. Ask how an unwanted result or a change to the proposal would be discussed and what information the person would receive before another decision. Broad own-tissue descriptions do not ensure freedom from later procedures, and use of the person’s own tissue does not guarantee normal sensation or function. Record which questions are still unanswered rather than filling them with a generic care pathway. This is proposal preparation; actual instructions, monitoring, review and any rehabilitation decisions must come from the qualified services that accept responsibility.

Lesson objective

Organize health and medicine questions for the responsible breast, reconstructive and anesthesia teams; qualified clinicians decide relevant investigations and preparation, and the course supplies no test order, medicine change or clearance.

Topics

• Organize the history questions without assessing eligibility: A preparation discussion starts with information the responsible clinicians need to review. ASPS identifies medical conditions, allergies, previous treatments and surgery, medicines and supplements, and substance-use history as consultation topics. Ask the team how relevant breast, oncology and other health information should reach them through actual care. Mark an unavailable detail as unavailable; do not reconstruct it from memory inside a teaching example. In this course, use only invented information and keep actual records private. A completed educational history outline does not establish that the clinical record is complete or that the person is eligible for any proposal. Assessment and any follow-up questions remain the qualified team’s work.
• Ask who decides and explains investigations: General preparation pages mention evaluation and possible investigations, but those examples do not tell an adult which tests to arrange. Ask which responsible clinician decides whether an investigation is needed, what question it would address and who explains or reviews the result in the actual care context. Distinguish a proposed investigation from a completed result and from a clinical decision. An educational checklist should leave those statuses open rather than marking a person cleared. The NHS mastectomy page and ASPS preparation page support asking about individual preparation; their generic lists are not transferred into a reconstruction testing package. Breast, reconstructive and anesthesia responsibilities should be clarified with the real teams.
• Resolve medicine questions through qualified care: Medicine and supplement questions need a responsible clinical explanation rather than an educational answer. Ask who reviews the person’s current medicines, allergies and supplements, who provides any individual instructions, and how questions involving more than one prescribing service will be resolved. The ASPS preparation page contains general wording about medicine adjustments and substances; this course uses that wording only to identify questions. It supplies no medicine name to start or stop, dose, substitution or timing. If an invented example has missing instructions, leave them missing and write a question for the team. Neither a course purchase nor a completed question sheet can replace an actual prescription or an agreed preparation instruction.
• Keep preparation instructions and responsibility clear: Ask which service provides individual preparation instructions, how the person receives them in an understandable form, and whom to contact if a question remains or different messages appear inconsistent. Separate the instructions that actually apply from information copied from a general webpage. Questions about health history, smoking or other substance use should be addressed by the qualified team without the course prescribing a schedule or judging suitability. A preparation note can help identify an unresolved question, but it cannot provide anesthesia advice, clinical clearance or permission to alter cancer treatment. The essential preparation responsibilities introduced in Foundation remain necessary whatever educational package an adult chooses.

Lesson objective

Identify personally relevant travel, help, dependent care and work questions and ask which arrangements are actually confirmed; a fictional support plan supplies no accepted care, recovery timetable or prescribed activity.

Topics

• Make travel and discharge arrangements questions: Travel planning needs the actual service’s explanation of where care occurs, possible discharge arrangements and what help may be required. Ask how travel to the relevant setting and later reviews will be discussed, especially when reconstruction is provided away from home. Keep a proposed journey separate from a clinically acceptable arrangement and from help a person has agreed to provide. ASPS recovery questions identify discharge and review as topics, while its consultation questions raise recovery help. They do not establish a discharge date, permission to travel or that a particular mode of transport is suitable. Record practical uncertainties so the team can address them within the actual proposal.
• Distinguish offered home help from confirmed support: An adult may have relatives or friends who offer help, but the tasks, availability and limits of that offer need discussion. Ask the care team what support should be considered for the individual proposal, then distinguish an offer from an arrangement the people involved have actually confirmed. An educational example can list questions about ordinary household help without deciding who must perform clinical tasks or assuming that a friend is a qualified caregiver. BAPRAS discusses home help and individual aftercare; NHS describes specialist-team support. These pages do not supply a helper, necessary equipment or a care commitment. Keep a gap visible when help, access or responsibility remains uncertain.
• Raise dependent care and work without setting dates: Practical priorities can include caring for an adult dependent, paid work, household responsibilities and access needs. Describe the tasks that matter in concrete terms, then ask the qualified team how the actual proposal affects questions about help and activity. Do not turn a generic recovery estimate into a leave period, a work-return date or permission to lift, drive or exercise. ASPS and NHS recovery material supports asking about activity and support; it does not determine the answer for a particular adult. Educational planning should show which questions require clinical explanation and which arrangements require agreement with other people. A list of concerns does not establish either agreement.
• Keep practical gaps connected to responsible care: A useful practical question page distinguishes what has been proposed, what has been offered and what is still unknown. Ask whom to approach when distance, access, support or an unexpected change makes an arrangement uncertain. Clinical teams must clarify their responsibilities; an ordinary supporter’s agreement cannot stand in for professional care. GMC continuity guidance supports questions about the lead team and the parts of care each service handles, rather than proof that an arrangement exists. BAPRAS recovery material supports asking about actual follow-up and home help. A fictional plan should end with unresolved questions, not a declaration that travel, dependent care or home recovery is safe or fully organized.

Lesson objective

Ask who provides individual wound, device or donor-site instructions and how uncertain work, driving, exercise and practical tasks are resolved; no general example supplies a care protocol, exercise prescription or activity permission.

Topics

• Ask which written instructions apply: Written instructions should relate to the individual care that the actual service has agreed to provide. Ask who supplies them, which procedure or site they cover and how the person can obtain an understandable explanation of anything unclear. Where more than one team is involved, ask how applicable instructions are identified and inconsistent messages resolved. ASPS and NHS descriptions support requesting individual care directions, but their general wording is not a wound, drain or medicine protocol. A course handout cannot establish that the adult has received the relevant instructions. Keep an absent document or unclear instruction marked as an unanswered question instead of filling it from the internet.
• Clarify equipment and site-care questions: Ask whether the actual proposal involves dressings, drains, support garments or other supplies, who explains any necessary use and who is responsible for questions about them. Own-tissue proposals may also require instructions covering a donor area, so ask how both sites are addressed when relevant. Mentioning an item identifies a question; it does not recommend buying it or show how to use it. The ASPS recovery page describes possible dressings and drains and emphasizes specific instructions. BAPRAS describes technique-dependent aftercare. Neither makes a supply necessary for every adult or establishes availability, sterility, a home-care method or a timetable for removal or change.
• Describe activity questions concretely: Instead of asking only when normal life resumes, name the activities that matter: a particular work task, driving, exercise or an ordinary household responsibility. Ask who can answer each question in the actual clinical context and how uncertainty will be reviewed. A description of the task helps the conversation, but the course does not assess whether it is safe or prescribe a modified version. ASPS asks about resuming activity; NHS describes recovery and team advice. Their general estimates cannot answer an individual question after combined treatment or donor-site surgery. An educational task list should remain a request for qualified explanation, without thresholds, repetitions, weights, return dates or permission.
• Keep changes and unclear directions open to review: Individual instructions may need clarification when the care context or proposal changes. Ask how the responsible service records updated directions and how the person knows which explanation applies. A general results page emphasizes individualized instructions and the possibility of further procedures; it does not allow a learner to decide that healing is complete or that a new activity can begin. BAPRAS aftercare discussion supports asking about review of the actual recovery situation. This lesson therefore deepens the essential instructions questions already introduced in Foundation. Completing a course exercise neither confirms understanding of clinical directions nor replaces the qualified explanation, review and contact arrangements that actual care requires.

Lesson objective

Prepare questions about reaching the actual responsible team for new, persistent or changing concerns and when ordinary contacts are unavailable; the course supplies no diagnosis, reassurance, triage rule or guaranteed response.

Topics

• Identify qualified contact responsibility: Essential contact questions should be addressed before an individual care decision, irrespective of the educational package. Ask which named service accepts responsibility for recovery questions, which concerns it covers and how the person reaches qualified advice. Distinguish the responsible clinical contact from a reception desk, an information page or a course contact. ASPS recovery material supports obtaining individual instructions about concerns and follow-up. GMC continuity guidance supports asking who holds each part of care. A name or telephone number written on an educational sheet does not prove that a service has accepted responsibility, is available or will respond. These arrangements require confirmation with the actual qualified team.
• Ask about in-hours, out-of-hours and unavailable contacts: A contact discussion needs to cover the situation in which the usual service is closed, unreachable or unable to answer. Ask for the actual in-hours and out-of-hours arrangements and the qualified route when an ordinary contact is unavailable. Also ask how the local service explains escalation and urgent or emergency access in its jurisdiction. The NHS mastectomy page has UK-specific urgent and immediate-action panels; they support asking for a local written route, not exporting its numbers or thresholds to every learner. GMC continuity guidance supports responsibility questions, but does not provide a local contact. This lesson creates no decision tree about which symptom needs which response or when to wait.
• Raise changing concerns without diagnosing them: New, persistent or changing concerns need the actual qualified service’s explanation of how they should be reported and assessed. An educational note can help formulate a question about the contact arrangement without identifying the cause or labeling a change normal. For a device proposal, ask how implant-related questions reach appropriate qualified review as well as how other recovery questions are handled. FDA device information supports discussing changes with clinicians; ASPS supports individual concern instructions. Neither supplies this course with a complete symptom checklist or a basis for reassurance. The lesson does not decide urgency, diagnose infection or device failure, or establish that an absence of listed symptoms means safety.
• Keep communication gaps distinct from clinical assessment: A course exercise may identify that a qualified contact, its availability or a fallback route has not been confirmed. That gap should remain explicit in the educational output rather than being repaired with an invented service or a promise of response. Ask the actual team how relevant information passes to the person or service receiving a concern, and who holds responsibility while care is shared. GMC continuity guidance supports these questions about communication and ownership. NHS and ASPS material supports obtaining individual concern and escalation instructions. A well-organized list can help a discussion, but it neither assesses a person’s condition nor guarantees timely access, accepted handover or effective treatment. For an actual recovery concern, seek qualified advice rather than waiting to complete an educational task.

Lesson objective

Clarify actual reviews and responsibility across breast, reconstructive, oncology and rehabilitation services, including distance or provider changes; a contact list or appointment question establishes no accepted relationship or agreed care.

Topics

• Separate the purposes of continuing reviews: Continuing care can involve different questions for breast, reconstructive, oncology and rehabilitation services. Ask what each proposed review is intended to address and which team holds responsibility, rather than assuming one appointment covers every purpose. NCI discusses reconstruction follow-up and possible rehabilitation support; ASPS asks about returning for follow-up care. These descriptions do not set an individual calendar or prove that a service has accepted the adult. Record whether a review is only a question, proposed through actual care, or genuinely confirmed by the service. The course’s fictional examples leave those distinctions visible and do not decide the need, timing or content of a clinical appointment.
• Ask how teams share responsibility: Ask who the lead team is, which clinicians or services are involved and how relevant decisions and concerns pass between them. If breast and reconstructive services work in different locations, ask how the actual coordination is arranged. BAPRAS describes collaboration and possible referral between breast and plastic services in a UK setting; it does not establish that every technique or service is currently available locally. GMC guidance supports questions about responsibility and information transfer across teams. An educational diagram should therefore show unanswered ownership questions rather than allocate real clinical duties. A referral request, provider name or courteous conversation does not establish that a named service has taken over care.
• Clarify rehabilitation and delegated work: If rehabilitation or another support service is discussed, ask what the referral would address, who decides it is appropriate and who explains the individual plan. NCI notes the possible role of qualified physical therapy after reconstruction; this supports a referral question without supplying exercises. Ask about the knowledge, skills and support of people carrying out delegated work, while avoiding a judgment based on a title or photograph. GMC professional guidance supports those delegation questions, and NHS encourages questions to the actual team about recovery and support. A fictional provider list proves no competence, access or accepted responsibility. The clinical and rehabilitation services determine any actual activities and instructions.
• Plan questions about distance or a provider change: Distance, a move or a change of service can create questions about continuing responsibility. Ask how relevant clinical information and agreed review decisions would be transferred, how the receiving service’s role would be confirmed and how unresolved concerns would remain visible. GMC guidance distinguishes clear clinical records from a person’s own question list and supports asking about transfer of responsibility. It does not guarantee a seamless handover or a new appointment. The educational brief should record a transfer question without becoming the clinical record. Ask the actual services how their arrangements work, including responsibility when contacts change; do not assume that a former provider’s contact details or a requested referral establishes ongoing care.

Lesson objective

Ask about optional later nipple-areola, appearance or other-breast proposals, their risks and whether further procedures are wanted; rebuilding appearance establishes no restored sensation or feeding, operative instruction or mandatory next stage.

Topics

• Keep nipple and areola proposals optional: A reconstructed breast mound does not require the person to choose another appearance procedure. Ask whether nipple reconstruction, areola tattooing, a removable nipple form or no additional stage is a relevant discussion, and which of those possibilities are actually available. NCI and BAPRAS describe later appearance options, but their descriptions do not supply a preferred look or a mandatory final step. A removable form is distinct from surgery or tattooing and is not supplied by the course. Leave timing and suitability to the qualified discussion, including the actual treatment context. The person’s chosen wishes may differ from another adult’s and should not be inferred from a photograph or a generic reconstruction story.
• Distinguish appearance from sensation and feeding: Questions about nipple or areola appearance should remain distinct from questions about feeling and breast function. BAPRAS explicitly separates the look of a reconstructed nipple from normal nipple sensation. ASPS also describes sensory uncertainty and lasting scars after reconstruction. Ask the team what these limits mean in the actual mastectomy and treatment history rather than assuming that a later appearance procedure restores function. FDA’s reconstruction-related feeding statement concerns loss of tissue and milk-producing glands on the affected side; augmentation experience cannot answer that question after mastectomy. The lesson predicts neither remaining-breast feeding capacity nor sensory recovery and supplies no lactation plan or assurance that a procedure will restore either.
• Ask about fat transfer or other appearance adjuncts: If fat transfer, also called lipomodelling, or another appearance adjustment is proposed, ask what concern it is intended to address and what benefits, risks and uncertainties the qualified clinician expects to discuss. BAPRAS describes fat transfer as a possible adjunct and notes that repeated stages may be considered. This creates questions about the actual proposal rather than a promise that a contour concern will be corrected. Keep any proposed source-area effects, further appointments, instructions and costs for the real discussion. The course does not describe harvesting or injection, select a technique, declare the procedure minor or safe, or decide how many stages an adult should have.
• Question other-breast surgery and further corrections: A proposal to adjust the reconstructed breast or operate on the other breast needs its own discussion of purpose, alternatives, risks and voluntary preference. Ask whether another procedure is wanted and what remains uncertain if it is declined. NCI and the BAPRAS materials describe possible matching or adjustment procedures, while ASPS warns that results are not guaranteed. None makes additional surgery inevitable or assures symmetry. Keep an appearance concern separate from a clinical need and from an agreed operation. The qualified teams must consider the actual breast and treatment context; the course gives no operative instruction, cancer-management advice, timing decision or promise that another stage will produce satisfaction.

Lesson objective

Ask which breast or oncology review and any device monitoring apply to the actual reconstruction and retained breast tissue, and which records should be kept; no universal imaging modality, interval, screening calendar or lifespan is supplied.

Topics

• Ask about actual breast and oncology follow-up: Breast or oncology follow-up concerns the person’s actual mastectomy, treatment history and any remaining breast tissue. Ask which team explains the review relevant to that context and how questions about a reconstructed side are distinguished from care of another breast. NCI’s follow-up discussion helps identify these separate purposes, but its generic statements do not supply an imaging rule for every reconstruction or remaining-breast situation. Do not infer a screening timetable, examination method or permission to omit review from an educational example. The responsible clinicians decide the individual plan. A course question sheet should identify its purpose and owner without replacing oncology advice or interpreting a change in the breast.
• Keep device monitoring a separate question: When a reconstruction includes an implant, ask which review concerns the device itself and who explains the proposed monitoring. A device question is not answered simply by naming a breast or oncology appointment. FDA discusses silent silicone implant rupture and includes MRI and ultrasound information; the lesson uses that material to identify a device-specific question, without directing the learner to either investigation or an interval. It does not repeat an MRI-only rule from a broader NCI comparison section. A normal-looking reconstruction or an educational statement about imaging cannot establish device integrity. The actual team must interpret the device, history, labeling and circumstances when explaining relevant review.
• Avoid a universal device lifespan or exchange rule: FDA states that implants are not lifetime devices, and the older BAPRAS/ABS guide discusses possible later implant surgery. Those descriptions support questions about future commitments, rather than a prediction of how long one device will last. Ask who reviews the actual situation and how a later proposal would be explained if concerns or preferences change. Keep possible further surgery distinct from inevitable surgery, a fixed exchange deadline or permission to retain a device without review. A warranty or funding statement cannot establish device integrity or remove clinical uncertainty. The course selects neither an operation nor a date and guarantees no satisfactory result from a future procedure.
• Ask how device information and review decisions are recorded: Ask what actual device information should be retained through clinical care, who provides it and how review decisions and unresolved questions are recorded. FDA identifies patient labeling and a device card as parts of US device communication. GMC supports questions about clear clinical records and responsibility across teams. A device card can help identify a device, but it is not a complete breast or oncology history, evidence of current integrity or proof of accepted follow-up. In educational examples, use an invented blank placeholder instead of real identifiers or records. The question brief should leave missing information explicit and distinguish its own notes from the clinical record and any agreed review plan.

Lesson objective

Outline a fictional adult brief using invented details to separate history, gaps, priorities, broad alternatives, proposal questions, essential risks and care commitments; retain source remit and uncertainty without actual private records, assessment, consent, clearance or outcome prediction.

Topics

• Separate invented history, gaps and chosen priorities: A fictional consultation brief can start with clearly labeled invented background, explicit information gaps and the adult’s chosen priorities. ASPS identifies goals and relevant history as consultation topics; GMC emphasizes finding out what matters rather than assuming values. Use those concepts to make the brief readable while leaving personal assessment to clinicians. A statement such as “the example adult wants to discuss another scar” is a preference for the conversation, not evidence of suitability or a selected operation. Keep actual breast, treatment, medicine and device records out of course work. This teaching format is original, and none of the source organizations supplies the invented person or endorses the completed brief.
• Keep alternatives, proposal questions and uncertainty distinct: The brief should distinguish broad alternatives from questions about a proposal that actual clinicians might make. Include room to discuss reconstruction, no reconstruction and other reasonable options without converting them into a ranking. Ask for an individual explanation of benefits, harms and uncertainty in an understandable form. GMC supports that dialogue and voluntary reflection; ASPS supports asking about the qualified surgeon’s proposal and potential risks. The brief itself cannot examine a person, make a recommendation or certify informed consent. A question about timing is not permission to delay cancer treatment, and an unanswered risk question should stay visible rather than being filled with a population statistic or reassurance.
• Bring essential care and costs into the brief: Include questions about essential risks, actual financial commitments, individual preparation, practical help, instructions, supplies, review and qualified contacts. These matters belong to the actual care discussion regardless of whether the adult buys Foundation or Full; their introduction before lesson 10 remains the course’s boundary. ASPS questions about help, complications and dissatisfaction support asking who explains the proposal’s responsibilities. GMC supports clear explanations and care ownership. Do not turn an unanswered question into a promise of service, payment, revision or access. The authored brief can organize missing information, but actual consent, accepted care and applicable financial terms require their own qualified and service-specific processes.
• Add source remit and an open-question ending: Close the fictional brief with a short source note explaining that US patient or regulatory material and UK professional or service descriptions have different remits. Preserve the registered dates and access limitations rather than presenting every page as a current local clinical instruction. Link each question category to the relevant source concept, while marking the exercise format as original teaching design. GMC recording guidance helps distinguish a clinical record from a learner’s note. Finish with the important unanswered questions and who should explain them through actual care, rather than a declaration of readiness. The brief gives no diagnosis, decision, competence, consent, clearance, funding entitlement or guaranteed outcome.